ARTICLE | Company News
Genmab, Roche antibody deal
May 7, 2001 7:00 AM UTC
Genmab (CSE:GEN; NMarkt:GE9D) will use its UltiMAb technology and preclinical assays to develop human antibodies against disease targets identified by F. Hoffmann-La Roche (SWX:ROCZ). The collaboratio...